Anastrozolex – 1mg/tab

Description

History: Anastrozole, introduced by Astra Zeneca, was considered revolutionary for cancer treatment. It was the first next-generation Aromatase Inhibitor (AI) and remains one of the most effective options available.

Method of Administration: Anastrozole is administered orally.

Drug Class: Aromatase Inhibitor.

Primary Use: Euro-Pharmacies Anastrozole, like all anti-estrogens, helps regulate estrogen levels in the body. Besides preventing estrogenic side effects, managing estrogen levels can help users maintain a hard and dry appearance when using aromatizable drugs, which is crucial for success in competitions. Anastrozole achieves this by binding with the aromatase enzyme responsible for converting testosterone and other aromatizable drugs into estrogens. Unlike a suicide aromatase inhibitor, Anastrozole does not permanently bind with the enzyme, allowing for the possibility of estrogen rebound after discontinuation. This rebound is usually not significant, but for those who experience issues, gradually reducing the dosage over a few weeks before stopping the drug can help. Anastrozole’s advantage lies in its infrequent dosing schedule.

Anabolic-Androgenic Ratio: N/A.
Aromatizable: No. Exhibits anti-estrogenic activity.
Progestagenic Activity: No.
Methylated: No.

Euro-Pharmacies Standard Dosing Range and Cycle Length: Anastrozole is typically administered at a dosage of 0.5 mg every other day to 1 mg per day. The specific dosing requirements will depend on the number and type of…